The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer

ISSN： 1473-7140

Source： Expert Review of Anticancer Therapy, Vol.13, Iss.4, 2013-04, pp. : 427-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapies for Metastatic Esophagogastric Cancer

By Reddy Deepa

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 46-60

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab in the treatment of metastatic colorectal cancer

By Caprioni Francesco Fornarini Giuseppe

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 141-148

Future Medicine

Access to resources Recommend Favorite

Evolving Therapies and FAK Inhibitors for the Treatment of Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 10, 2010-12 ,pp. : 722-734

Bentham Science Publishers

Access to resources Recommend Favorite

Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 583-588

Spandidos Publications

Access to resources Recommend Favorite

Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF‐targeted therapies

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1461-1471

John Wiley & Sons Inc

Access to resources Recommend Favorite